{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-028425","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.029480+00:00","generated_at":"2026-05-15T02:22:55.107425+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"TriSalus Life Sciences Chief of Clinical Operations Jodi Devlin to retire October 1, 2026","bullets":["Jodi Devlin notified Company on April 24, 2026 of retirement as Chief of Clinical Operations.","Retirement effective October 1, 2026; Company expresses gratitude for her contributions.","Previously announced Dr. Richard Marshall as new Chief Medical Officer effective June 29, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-028425","json":"https://secwatch.observer/filing/0001628280-26-028425.json","markdown":"https://secwatch.observer/filing/0001628280-26-028425.md","text":"https://secwatch.observer/filing/0001628280-26-028425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/tlsi-20260424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:22:55.107425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"80772c891c","claim":"Jodi Devlin departed as Chief of Clinical Operations at TriSalus Life Sciences, Inc..","evidence_excerpt":"On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief of Clinical Operations"}],"fact_type":"executive_change"},{"claim_id":"eed195b25c","claim":"Dr. Richard Marshall was appointed as Chief Medical Officer at TriSalus Life Sciences, Inc..","evidence_excerpt":"As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}